YU219189A - Novi soj hantaan virusa rok 84/105, i vakcina za isti - Google Patents

Novi soj hantaan virusa rok 84/105, i vakcina za isti

Info

Publication number
YU219189A
YU219189A YU219189A YU219189A YU219189A YU 219189 A YU219189 A YU 219189A YU 219189 A YU219189 A YU 219189A YU 219189 A YU219189 A YU 219189A YU 219189 A YU219189 A YU 219189A
Authority
YU
Yugoslavia
Prior art keywords
vaccine
hantaan virus
stray
rock
new
Prior art date
Application number
YU219189A
Other languages
English (en)
Inventor
H.W. Lee
S.J. Riu
C.N. An
Original Assignee
Korea Green Cross Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Green Cross Corp. filed Critical Korea Green Cross Corp.
Publication of YU219189A publication Critical patent/YU219189A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12111—Hantavirus, e.g. Hantaan virus
    • C12N2760/12134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12111—Hantavirus, e.g. Hantaan virus
    • C12N2760/12151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

NOVI SOJ HANTAAN VIRUSA ROK 84/105, I VAKCINA ZA ISTI. Ovaj pronalazak se odnosi na Hantaan virus i vakcinu za isti. Hantaan virusna vakcina može da se izradi kao što sledi: Soj Hantaan virusa ROK84/105 se izoluje iz ljudskog tela kao standardni soj za zasejavanje, injicira jedan starom novorodjenom mišu ili pacovu, koji se gaji u toku približno 10 dana. Posle toga mozak miša se obradjuje sa eti alkoholom i protamin sulfatnim rastvorom, nastali materijal se prečišćava i inaktiviše, i dodaje se adjuvans krajnjem proizvodu.
YU219189A 1988-11-18 1989-11-17 Novi soj hantaan virusa rok 84/105, i vakcina za isti YU219189A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019880015199A KR900007952B1 (ko) 1988-11-18 1988-11-18 신규의 한탄바이러스 rok84/105 균주 및 이를 이용한 한탄바이러스 백신의 제조방법

Publications (1)

Publication Number Publication Date
YU219189A true YU219189A (sh) 1992-12-21

Family

ID=19279386

Family Applications (1)

Application Number Title Priority Date Filing Date
YU219189A YU219189A (sh) 1988-11-18 1989-11-17 Novi soj hantaan virusa rok 84/105, i vakcina za isti

Country Status (5)

Country Link
US (1) US5183658A (sh)
JP (1) JPH02242674A (sh)
KR (1) KR900007952B1 (sh)
HU (1) HU206050B (sh)
YU (1) YU219189A (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1059347C (zh) * 1992-03-27 2000-12-13 牧岩生命工学研究所 制备肾病综合症出血热疫苗的方法
CA2166104A1 (en) * 1993-06-24 1995-01-05 Stuart T. Nichol Nucleic acids of a novel hantavirus and reagents for detection and prevention of infection
WO1997027302A1 (fr) * 1996-01-25 1997-07-31 Cheil Jedang Corporation Vaccin contenant une proteine du capside nucleique du virus d'origine humaine dit 'hantaan', exprimee par escherichia coli
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
SE0100011D0 (sv) * 2001-01-03 2001-01-03 Eurocine Ab Karolinska Inst Sc Virus vaccine formulation
NZ539107A (en) * 2002-09-27 2008-11-28 Powderject Res Ltd Nucleic acid coated particles

Also Published As

Publication number Publication date
KR900007952B1 (ko) 1990-10-23
KR900007436A (ko) 1990-06-01
JPH02242674A (ja) 1990-09-27
JPH0553475B2 (sh) 1993-08-10
US5183658A (en) 1993-02-02
HU895956D0 (en) 1990-02-28
HUT55641A (en) 1991-06-28
HU206050B (en) 1992-08-28

Similar Documents

Publication Publication Date Title
Cohen et al. A nerve growth-stimulating factor isolated from sarcom as 37 and 180
ATE148920T1 (de) Verfahren zur enzymatischen herstellung von alpha-sialylierten oligosaccharid-glykosiden
ES2077028T3 (es) Vacunas vivas.
MX9206041A (es) Proceso para producir interferon inmune humano.
ES2131069T3 (es) Expresion de proteinas recombinantes en bacterias atenuadas.
FI860015A (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
KR900013082A (ko) Pf1022 물질, 그 생산방법 및 그 물질을 포함한 구충제 조성물
ES278057A1 (es) Procedimiento para la preparación de lincomicina
ATE192653T1 (de) Anwendungen von acemannan
YU219189A (sh) Novi soj hantaan virusa rok 84/105, i vakcina za isti
Chinzei Induction of histolysis by ecdysterone in vitro: breakdown of anterior silk gland in silkworm, Bombyx mori (Lepidoptera: Bombycidae)
SE8104482L (sv) Forfarande for framstellning av ett faktor viii (ahf)-hogkoncentrat
KR920004570A (ko) 사람 mk 단백질을 암호하는 유전자, 이를 포함하는 발현 벡터 및 숙주 세포, mk단백질의 생산 방법 및 사용방법
ATE73850T1 (de) Verfahren zur herstellung von 2-keto-dglukars|ure.
US4468460A (en) Method of human cell culture
KR910006483A (ko) 재조합 아프로티닌 변이체, 균질하게 프로세싱된 아프로티닌 변이체의 미생물을 이용한 유전공학적 제조 방법 및 그의 치료 용도
Edwards LIFE HISTORY STUDIES OF SELECTED BRITISH CERAMIUM SPECIES 1
ES2043610T3 (es) Procedimiento para la produccion de un polipeptido hibrido del tipo activador de plasminogeno.
ATE139568T1 (de) Achromobacter-protease-i-gen sowie genprodukt
Levi-Montalcini Tissue and Nerve Growth Promoting Factors: Biological Aspects of Specific Growth Promoting Factors
Samarut Isolation of an erythropoietic stimulating factor from the serum of anemic chicks
KR880000579A (ko) 베리셀라-죠스터 바이러스의 생산방법
Sulkin et al. Effect of zymosan on bacteriophage clearance
Bertsch et al. Appearance of growth-inhibiting activity (G1 chalone) during ontogenetic development of rat and chick epidermis in vivo and in vitro
ES2056123T3 (es) Clonacion del gen que codifica la enzima isoamilasa y su empleo en la produccion de dicha enzima.